The problem is that many discount any prospects related to H Pylori and Superbug.
The appointment of staff hass been very professional I think.
Just a matter of waiting. Doesn't that apply to most biotechs?
There was a TA reading issued a couple of days ago, I don't know if it is still valid.
Gerry
Gerry
- Forums
- ASX - By Stock
- CMQ
- risk versus reward
risk versus reward, page-5
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)